Scientists believe physiological vitals collected by smart sensors, not self-reported surveys are a better way to test vaccine safety.

Researchers from the University of Haifa said that women reported 1.9 times as many side effects as men after receiving the Pfizer vaccine.

The trial began earlier this week at Sheba Medical Center with 150 medical personnel who had received a booster shot in August.

Israel is set to begin vaccinating children aged 5-11 against COVID-19 with the Pfizer-BioNTech vaccine at the beginning of next week.

The BriLife jabs arrived in Georgia over the weekend to begin the trial, which will run simultaneously with trials in Israel.

This guest post by the head of innovation at Israeli startup Air Doctor looks at the strategies behind the countries with the highest vaccine rates.

Reopening the economy requires balancing individual rights, including of inoculation-refusers, with public welfare, but the government hasn’t weighed in definitively

When people test COVID positive, viral loads are 4 times lower if they’re vaccinated, according to first-of-its-kind Israeli research.

Israel is administering more vaccine doses per 100 people than anywhere else: Bahrain is second, and Iceland is third as of December 30.

Segev Harel, 26, from northern Israel, becomes the first Israeli volunteer to get the coronavirus vaccine developed by the Israel Institute for Biological Research.

Scientists at the Israel Institute for Biological Research say a single dose was able to protect the hamsters against SARS-CoV-2 and showed "rapid and potent induction of neutralizing antibodies.'

The Rehovot-based firm said it completed the manufacturing of the first batch of its plasma-derived IgG product for the novel coronavirus.

Netanyahu said that to ensure both the public health and national prosperity, countries must all work together.

StartupBlink, an Israeli-founded global startup ecosystem map and research center, put together a global map tracking innovative projects across the world.

Researchers at the Migal Institute in northern Israel say they developed an effective vaccine against IBV, a fowl virus, and are now working to adapt it to COVID-19.